Penicillin Allergy Impact and Management.

Delabeling Drug allergy Oral challenge Penicillin allergy

Journal

Infectious disease clinics of North America
ISSN: 1557-9824
Titre abrégé: Infect Dis Clin North Am
Pays: United States
ID NLM: 8804508

Informations de publication

Date de publication:
Dec 2023
Historique:
pubmed: 4 8 2023
medline: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

There is international evidence that penicillin allergies are associated with inferior prescribing and patient outcomes. A host of tools now exist from assessment (risk assessment tools, clinical decision rules) to delabeling (the removal of a beta-lactam allergy via testing or medical reconciliation) to reduce the impact of these "labels" in the hospital and community setting, as a primary antimicrobial stewardship intervention.

Identifiants

DOI: 10.1016/j.idc.2023.06.005 PMID: 37537003
pubmed: 37537003
pii: S0891-5520(23)00049-1
doi: 10.1016/j.idc.2023.06.005
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-822

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Rebekah H Wrenn (RH)

Duke University Medical Center, Durham, NC, USA; Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USA. Electronic address: rebekah.wrenn@duke.edu.

Jason A Trubiano (JA)

Department of Infectious Diseases, Centre for Antibiotic Allergy and Research, Austin Health, Melbourne, Australia; Department of Infectious Diseases, University of Melbourne, at The Peter Doherty Institute for Infection and Immunity, Victoria 3000, Australia; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Classifications MeSH